【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables17
1.2 List of Figures 22
2 Introduction 24
2.1 Catalyst 24
2.2 Upcoming Related Reports 25
3 Disease Overview 26
3.1 Classification of Seizures 28
3.2 Etiology and Pathophysiology 29
3.2.1 Etiology 29
3.2.2 Pathophysiology 32
3.2.3 Prognosis 38
3.2.4 Quality of Life 39
4 Epidemiology 40
4.1 Risk Factors and Comorbidities 40
4.1.1 Risk factors in newborns often include brain malformations and lack of oxygen 40
4.1.2 Genetic factors and head trauma are risk factors in adults and children 41
4.1.3 Common seizure triggers include lack of sleep, stress, and photosensitivity 41
4.1.4 Epilepsy comorbidities in adults and children include pain disorders 41
4.1.5 Anxiety and depression are major epilepsy comorbidities 42
4.1.6 Epilepsy with a known cause can be prevented by the avoidance of head injuries 42
4.2 Global Trends 43
4.2.1 United States 44
4.2.2 5EU Markets (France, Germany, Italy, Spain, and UK) 45
4.2.3 Asia 46
4.3 Forecast Methodology 48
4.3.1 Sources Used 49
4.3.2 Forecast Assumptions and Methods 55
4.3.3 Sources Not Used 58
4.4 Epidemiologic Forecast 59
4.4.1 Total Active Prevalent Cases of Epilepsy 59
4.4.2 Total Lifetime Prevalent Cases of Epilepsy 61
4.4.3 Age-Specific Total Active Prevalent Cases of Epilepsy 63
4.4.4 Gender-Specific Total Active Prevalent Cases of Epilepsy 64
4.4.5 Seizure-Specific Total Active Prevalent Cases of Epilepsy 65
4.5 Discussion 66
4.5.1 Conclusion on Epidemiological Trends 66
4.5.2 Limitations of the Analysis 67
4.5.3 Strengths of the Analysis 67
5 Disease Management 68
5.1 Diagnosis 68
5.2 Treatment Guidelines 69
5.3 Clinical Practice 70
5.4 US 77
5.4.1 Diagnosis 77
5.4.2 Clinical Practice 78
5.5 UK 81
5.5.1 Diagnosis 81
5.5.2 Clinical Practice 82
5.6 France 83
5.6.1 Diagnosis 83
5.6.2 Clinical Practice 84
5.7 Germany 86
5.7.1 Diagnosis 86
5.7.2 Clinical Practice 87
5.8 Spain 89
5.8.1 Diagnosis 89
5.8.2 Clinical Practice 90
5.9 Italy 91
5.9.1 Diagnosis 91
5.9.2 Clinical Practice 92
5.10 Japan 94
5.10.1 Diagnosis 94
5.10.2 Clinical Practice 95
5.11 India 96
5.11.1 Diagnosis 96
5.11.2 Clinical Practice 97
5.12 China 99
5.12.1 Diagnosis 99
5.12.2 Clinical Practice 100
6 Competitive Assessment 102
6.1 Overview 102
6.2 Strategic Competitor Assessment 104
6.3 Product Profiles – Major Brands 107
6.3.1 Keppra (levetiracetam) 107
6.3.2 Lamictal (lamotrigine) 113
6.3.3 Lyrica (pregabalin) 119
6.3.4 Vimpat (lacosamide) 123
6.3.5 Zonegran (zonisamide) 128
6.3.6 Banzel/Inovelon (rufinamide) 133
6.3.7 Trobalt/Potiga (retigabine/ezogabine) 137
6.3.8 Zebinix/Aptiom (eslicarbazepine acetate) 142
6.3.9 Fycompa (perampanel) 146
6.3.10 Older-Generation AEDs 149
7 Opportunity and Unmet Need 151
7.1 Overview 151
7.2 Unmet Needs 152
7.2.1 Refractory Epilepsy 152
7.2.2 Safety/Side Effect Profiles 152
7.2.3 Curative/Disease-Modifying Agents 153
7.2.4 Predictive Tools and Need for More Directed Treatments 154
7.2.5 Improved Preclinical Models and Clinical Trial Paradigms 155
7.2.6 Treatment Gap 156
7.3 Unmet Needs Gap Analysis 157
7.4 Opportunities 157
7.4.1 Disease-Modifying Agents 157
7.4.2 Improved Preclinical Models and Clinical Trial Paradigms 157
7.4.3 Treatment Gap 158
8 Pipeline Assessment 159
8.1 Overview 159
8.2 Clinical Trial Mapping 159
8.2.1 Clinical Trials by Country 159
8.3 Clinical Trials by Phase and Trial Status 161
8.4 Strategic Pipeline Assessment 162
8.5 Pipeline by Phases of Development 163
8.5.1 Phase III Pipeline 163
8.5.2 Phase III Pipeline – Reformulations/New Delivery Systems 163
8.5.3 Phase IIb Pipeline 164
8.5.4 Phase II Pipeline 164
8.5.5 Phase I Pipeline 165
8.5.6 Preclinical Pipeline 166
8.5.7 Discovery Pipeline 167
8.6 Pipeline by Mechanism of Action 167
8.7 Promising Drugs in Clinical Development 170
8.7.1 Brivaracetam 171
8.7.2 Ganaxolone 175
8.7.3 VX-765 180
9 Current and Future Players 184
9.1 Overview 184
9.2 Trends in Corporate Strategy 187
9.3 Company Profiles 189
9.3.1 UCB 189
9.3.2 Eisai 191
9.3.3 Pfizer 193
9.3.4 GlaxoSmithKline 195
9.3.5 Novartis 197
9.3.6 Abbott 199
9.3.7 Dainippon Sumitomo Pharma 201
10 Market Outlook 203
10.1 Global Markets 203
10.1.1 Forecast 203
10.1.2 Drivers and Barriers – Global Issues 207
10.2 United States 209
10.2.1 Forecast 209
10.2.2 Key Events 213
10.2.3 Drivers and Barriers 213
10.3 France 215
10.3.1 Forecast 215
10.3.2 Key Events 219
10.3.3 Drivers and Barriers 219
10.4 Germany 221
10.4.1 Forecast 221
10.4.2 Key Events 225
10.4.3 Drivers and Barriers 225
10.5 Italy 227
10.5.1 Forecast 227
10.5.2 Key Events 231
10.5.3 Drivers and Barriers 231
10.6 Spain 233
10.6.1 Forecast 233
10.6.2 Key Events 237
10.6.3 Drivers and Barriers 237
10.7 United Kingdom 239
10.7.1 Forecast 239
10.7.2 Key Events 243
10.7.3 Drivers and Barriers 243
10.8 Japan 246
10.8.1 Forecast 246
10.8.2 Key Events 249
10.8.3 Drivers and Barriers 249
10.9 India 252
10.9.1 Forecast 252
10.9.2 Key Events 255
10.9.3 Drivers and Barriers 255
10.10 China 258
10.10.1 Forecast 258
10.10.2 Key Events 261
10.10.3 Drivers and Barriers 261
11 Appendix 263
11.1 Bibliography 263
11.2 Abbreviations 278
11.3 Methodology 282
11.4 Forecasting Methodology 282
11.4.1 Prevalent Epilepsy Patients 282
11.4.2 Percent Drug-Treated Patients 283
11.4.3 Drugs Included in Each Therapeutic Class Based on MOA 283
11.4.4 Launch Dates and Patent and Market Exclusivity Expiry Dates 284
11.4.5 General Pricing Assumptions 286
11.4.6 Individual Drug Assumptions 287
11.4.7 Generic Erosion 300
11.4.8 Pricing of Pipeline Agents 300
11.5 Physicians and Specialists Included in this Study 301
11.6 Primary Research – Prescriber Survey 302
11.7 About the Authors 303
11.7.1 Authors 303
11.7.2 Epidemiologist 304
11.7.3 Global Head of Healthcare 304
11.8 About GlobalData 305
11.9 Disclaimer 305
【レポート販売概要】
■ タイトル:てんかん(Epilepsy):グローバル治療薬予測と市場分析■ 英文:PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
■ 発行日:2013年12月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC72PIDR
■ 調査対象地域:グローバル
- 世界のシロップ及びスプレッド市場のM&A動向(2014年6月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global syrups & spreads market during June 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global syrups & spreads market throughout the month. Additionally, the report provides an overview of a …
- 世界のシステムオンチップ・テスト装備市場:Global System-on-Chip (SOC) Test Equipment Market 2014-2018TechNavio's analysts forecast the Global System-on-Chip (SOC) Test Equipment market to grow at a CAGR of 3 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for semiconductors. The Global SOC Test Equipment market has also been witnessing the increasing demand for high-quality SOC test equipment. However, the cyclical nature of th …
- 絶縁の世界市場分析:製品別(ガラス繊維、発泡プラスチック、ミネラルウール)、用途別(住宅建設、工業用、HVACおよびOEM、非住宅建設)、セグメント予測、2014-2025The global insulation market is expected to reach USD 93.34 billion by 2024, according to a new report by Grand View Research, Inc. Rising importance of energy efficient buildings owing to escalating energy costs is expected to remain a key driving factor for global insulation market. Legislative frameworks such as new building codes by the European Union, energy efficiency improvement program by …
- 統合システムの世界市場分析:製品別(統合プラットフォーム/ワークロードシステム、統合インフラシステム)、サービス別(統合・インストール、コンサルティング、メンテナンス・サポート)、用途別(BFSI、IT・テレコム、小売、製造、ヘルスケア)、セグメント予測、-2020The global integrated systems market is expected to reach USD 24.02 billion by 2020. Accelerated business demands and intricate nature of IT challenges is anticipated to drive the global integrated systems market demand over the forecast period. The IT industry is highly dynamic in nature and characterized by technological advancements and innovation. Every few years the industry experiences tecto …
- フリップチップの世界市場2018-2022About Flip Chip Flip chip is a type of packaging type, which interconnects chip and package carriers or substrates using a conductive bump. Conductive bumps are placed on the die surface, which is flipped to connect the substrate directly. Technavio’s analysts forecast the Global Flip Chip Market Market to grow at a CAGR of 6.22% during the period 2018-2022. Covered in this report The report cover …
- Tcelna (Multiple Sclerosis):市場予測と分析(~2022)Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous …
- ネットワーク管理ソリューションの世界市場The network management market ecosystem encompasses industry players offering software, solutions and products, equipment vendors, third-party application vendors and system integrators. Prominent players in the network management market space are Cisco, Juniper Networks, IBM, HP, Dell, EMC, Brocade, and BMC Software amongst others. These companies play a critical role in simplifying network manag …
- GDI(直噴エンジン)システムの世界市場予測(~2025年)The gasoline direct injection (GDI) system market is projected to grow at a CAGR of 9.94% during the forecast period, to reach USD 11.28 Billion by 2025 from USD 5.29 Billion in 2017. The market is estimated to grow in the near future owing to benefits offered by the GDI system such as an increase in fuel efficiency, reduction in tailpipe emissions, and a drastic reduction in engine size without s …
- グローバルにおけるスマートグリッド市場動向:June 2014Smart Grid Review - June 2014 Summary A substantial number of smart grid developments took place in May 2014, including product launches, fundraising events and the announcement and completion of contracts and projects. A total of six major acquisitions took place in May. One was the acquisition of PowerSense, a Danish smart grid sensor and monitoring company, by Landis+Gyr, a global leader in the …
- 世界のmHealth(モバイルヘルス)アプリおよびソリューション市場mHealth is a successful integration of mobile technology and healthcare services that entail a revolution in the global healthcare solutions market. The global mHealth market is estimated to be valued at $6.6 billion in 2013 and is expected to reach $20.7 billion by 2018 at a healthy CAGR of 25.5%. The mobile healthcare market is broadly categorized into connected medical device and healthcare app …
- Liver Cirrhosis:グローバル臨床試験レビューH2, 2013Liver Cirrhosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H2, 2013" provides data on the Liver Cirrhosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cirrhosis. It includes an overview of the trial numbers and their recruitment status as …
- ドッキングステーションの世界市場2019-2023About this market The increasing availability of universal docking stations will trigger the docking station market growth during the forecast period. Universal docking stations are often connected to the latest laptops, notebooks, desktops, and some compatible tablets running either on Mac or Windows operating systems. Furthermore, increasing adoption of various styles of working concepts includi …
- 食品用香料の世界市場:種類(チョコレート、バニラ、果物、ナッツ)、原料(天然香料、合成香料)、用途、地域別分析Flavors are used in a wide range of products that include bakery, snacks, confectionery, meat, poultry, and seafood. The food flavors market, by origin includes natural and synthetic flavors. The food flavors market is driven by changing consumer trends and food preferences. The food & beverage (F&B) processing industry also influences the food flavors market. F&B manufacturers widely use syntheti …
- 世界のテルル市場:市場規模、動向、メーカー動向Scope The report presents a thorough study of tellurium, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing tellurium production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: tellurium p …
- リチウムの世界市場:炭酸リチウム、水酸化リチウム、リチウム濃縮物、リチウム金属、ブチルリチウム、塩化リチウムAbout the Lithium Market Lithium is recovered from brine, pegmatites, and sedimentary rocks. It is extracted from brine in the form of lithium chloride. Lithium is derived from spodumene, a commercially exploited hard rock mineral, through acid fusion. Lithium and its derivative compounds are used in many end-use segments such as batteries, ceramics and glass, lubricants, metallurgy, air treatment …